Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3P1V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,776
Award facts
- Contract value 100% obligated
- $36,776.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $36,776.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen auto-injectors (2 mL), with an ultimate completion date of December 31, 2025. This is a non-set-aside, competitively awarded contract issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems across the Department of Defense.
This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement with DLA, which enables the company to furnish a wide range of medications and medical supplies globally to support military healthcare programs. The contract represents the company's capability to fulfill specialized pharmaceutical needs through open competition and reflects its established role as a major prime vendor for the federal government's medical supply chain. The firm fixed-price structure and specific product designation indicate a defined procurement of this specialty pharmaceutical product for Defense Health Agency and other military healthcare customers.
Quick answers
Who was awarded contract SPE2DR26F3P1V?
SPE2DR26F3P1V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F3P1V worth?
The government has obligated $36,776 on SPE2DR26F3P1V.
Is contract SPE2DR26F3P1V an order under another contract?
Yes. SPE2DR26F3P1V is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3P1V competed?
The extent of competition for SPE2DR26F3P1V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award